Combined α2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle

Psychopharmacology

Volumn 159, Issue 1, 2001, Pages 105-110

  Ballmaier, Martina ^a   Zoli, Michele ^b   Mazzoncini, Rodolfo ^a   Gennarelli, Massimo ^c   Spano, Pier ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Augmentation strategy; Idazoxan; Noradrenaline; Raclopride; Sensorimotor gating; Treatment resistant schizophrenia

Indexed keywords

APOMORPHINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; IDAZOXAN; PHENCYCLIDINE; RACLOPRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG MECHANISM; DRUG POTENCY; MALE; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 0036135958     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100905     Document Type: Article

References (46)

1. Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation with dopamine receptor blockade
2. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
3. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
4. Prestimulus effects on human startle reflex in normals and schizophrenics
5. Gating and habituation of the startle reflex in schizophrenic patients
6. Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies
7. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
8. General pharmacology of clozapine
9. Animal models of the negative symptoms of schizophrenia
10. Measurement of startle response, prepulse inhibition, and habituation
11. Multiple transmitters modulate prepulse inhibition of startle: Relevance to schizophrenia
12. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade of review
13. 2 adrenoceptor blockade
14. 1 receptor agonist?
15. 2 receptors?
16. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia
17. Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
18. 2 receptor explain the action of atypical antipsychotics?: A new hypothesis
19. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle
20. Mechanisms of action of atypical antipsychotic drugs: A critical analysis
21. Normalization of information processing deficits in schizophrenia with clozapine
22. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens
23. Treatment refractory schizophrenia
24. 2-adrenoceptor antagonists
25. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine
26. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat
27. Parametric determinants in prestimulus modification of acoustic startle: Interaction with ketamine
28. Dopaminergic stimulation disrupts sensorimotor gating in the rat
29. Disorders of attention and perception in schizophrenia
30. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study
31. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study
32. Effects of dopamine antagonists in a two-way active avoidance procedure in rats - Interactions with 8-OH-DPAT, ritanserin and prazosin
33. What is an atypical antipsychotic?
34. Seroquel: Biochemical profile of a potential atypical antipsychotic
35. 1 receptor agonist
36. Psychosis: Pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?
37. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
38. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments in schizophrenia
39. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
40. Seroquel restores sensorimotor gating in phencyclidine-treated rats
41. Toward understanding the biology of a complex phenotype: Rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists
42. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: Enhancement of antipsychotic-like effects without catalepsy
43. The conditioned avoidance response test re-evaluated: Is it a sensitive test for the detection of potentially atypical antipsychotics?
44. 2 receptor blocking agent, ritanserin, in the rat
45. 2A receptor antagonist MDL100,907
46. 4receptor agonist